Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
J Investig Allergol Clin Immunol. 2022 Feb;32(1):1-12. doi: 10.18176/jiaci.0769.
Considerable progress has been made in the field of molecular biology in recent years, enabling the study of sensitization to the individual components of an allergenic source, a practice that has been termed molecular allergy diagnosis (MD) or component-resolved diagnosis (CRD). The present review provides the clinician with a practical approach to the use of MD by answering questions frequently asked by physicians on how MD can help improve the diagnosis of allergy in daily clinical practice. The article is divided into 3 sections. First, we provide a brief review of the importance for the clinician of knowing the main allergens in the different allergenic sources, their structure, and their in vitro cross-reactivity before approaching MD (section A). Second, we review the usefulness of MD in clinical practice (section B) and answer frequently asked questions on the subject. Finally, section C addresses the interpretation of MD and its integration with other tools available for the diagnosis of allergy.
近年来,分子生物学领域取得了相当大的进展,使得对过敏原的各个成分的致敏性研究成为可能,这种做法被称为分子过敏原诊断(MD)或成分分辨诊断(CRD)。本综述通过回答医生经常提出的关于 MD 如何帮助改善日常临床实践中过敏诊断的问题,为临床医生提供了一种实用的 MD 使用方法。本文分为 3 个部分。首先,在探讨 MD 之前,我们简要回顾了了解不同过敏原来源中的主要过敏原、它们的结构以及它们的体外交叉反应性对临床医生的重要性(A 节)。其次,我们回顾了 MD 在临床实践中的实用性(B 节)并回答了关于该主题的常见问题。最后,C 节讨论了 MD 的解释及其与其他可用于诊断过敏的工具的整合。